EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thermosensitive Mucoadhesive Intranasal In Situ Gel of Risperidone for Nose-to-Brain Targeting: Physiochemical and Pharmacokinetics Study

Mahendra Singh, Sanjay Kumar, Ramachandran Vinayagam iD, Ramachandran Samivel iD

Pharmaceuticals · 11.06.2025 · 18 (6) · 871

DOI: 10.3390/ph18060871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 11.06.2025. Verfasst von Mahendra Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Life and Applied Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Non-invasive central nervous system (CNS) therapies are limited by complex mechanisms and the blood–brain barrier, but nasal delivery offers a promising alternative. The study planned to develop a non-invasive in situ intranasal mucoadhesive thermosensitive gel to deliver CNS-active risperidone via nose-to-brain targeting. Risperidone, a second-generation antipsychotic, has shown efficacy in managing both psychotic and mood-related symptoms. The mucoadhesive gel formulations help to prolong the residence time at the nasal absorption site, thereby facilitating the uptake of the drug.

Methods

The poloxamer 407 (18.0% w/v), HPMC K100M and K15M (0.3–0.5% w/v), and benzalkonium chloride (0.1% v/v) were used as thermosensitive polymers, a mucoadhesive agent, and a preservative, respectively, for the development of in situ thermosensitive gel. The developed formulations were evaluated for various parameters.

Results

The pH, gelation temperature, gelation time, and drug content were found to be 6.20 ± 0.026–6.37 ± 0.015, 34.25 ± 1.10–37.50 ± 1.05 °C, 1.65 ± 0.30–2.50 ± 0.55 min, and 95.58 ± 2.37–98.03 ± 1.68%, respectively. Furthermore, the optimized F3 formulation showed satisfactory gelling capacity (9.52 ± 0.513 h) and an acceptable mucoadhesive strength (1110.65 ± 6.87 dyne/cm2). Diffusion of the drug through the egg membrane depended on the formulation’s viscosity, and the F3 formulation explained the first-order release kinetics, indicating concentration-dependent drug diffusion with n < 0.45 (0.398) value, indicating the Fickian-diffusion (diffusional case I). The pharmacokinetic study was performed with male Wistar albino rats, and the F3 in situ thermosensitive risperidone gel confirmed significantly (p < 0.05) ~5.4 times higher brain AUC0–∞ when administered intranasally compared to the oral solution.

Conclusions

Based on physicochemical, in vitro, and in vivo parameters, it can be concluded that in situ thermosensitive gel is suitable for administration of risperidone through the nasal route and can enhance patient compliance through ease of application and with less repeated administration.

Schlagwörter

Stichwörter der Autor:innen

CNS disordersblood–brain barrierdiffusionnon-invasivenose-to-brain targetingthermosensitive in situ gels

Autor:innen und Institutionen

  • Department of Biotechnology, College of Life and Applied Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea.
  • Formulation Research and Development, Naari Pharma Private Limited, Sec-5, Rudrapur 263153, India.
  • Cornea Research Chair, Department of Optometry, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.

ORCID-Profile: Ramachandran Vinayagam, Ramachandran Samivel

Zitieren

APA

Singh, M., Kumar, S., Vinayagam, R., & Samivel, R. (2025). Thermosensitive Mucoadhesive Intranasal In Situ Gel of Risperidone for Nose-to-Brain Targeting: Physiochemical and Pharmacokinetics Study. Pharmaceuticals, 18(6), 871. https://doi.org/10.3390/ph18060871

Vancouver

Singh M, Kumar S, Vinayagam R, Samivel R. Thermosensitive Mucoadhesive Intranasal In Situ Gel of Risperidone for Nose-to-Brain Targeting: Physiochemical and Pharmacokinetics Study. Pharmaceuticals. 2025;18(6):871. doi:10.3390/ph18060871

BibTeX
@article{Singh2025,
  author = {Singh, Mahendra and Kumar, Sanjay and Vinayagam, Ramachandran and Samivel, Ramachandran},
  title = {Thermosensitive Mucoadhesive Intranasal In Situ Gel of Risperidone for Nose-to-Brain Targeting: Physiochemical and Pharmacokinetics Study},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {6},
  pages = {871},
  doi = {10.3390/ph18060871}
}
Kostenlos starten →